OpenAI launches a $1 billion philanthropic push through its non-profit Foundation, targeting life sciences, economic impact, and community programs, but critics argue the tech giant is simply funding fixes to problems its own AI is creating.
Google's Gemini 3 dominates AI benchmarks with 8 million enterprise seats while Anthropic's Claude Code rockets to $1 billion in annual revenue in just six months, as AI specialists like Abridge, World Labs, and Hume AI drive major breakthroughs across healthcare, robotics, and emotional intelligence.
A real-world AI tool deployed across 16 Nairobi clinics is cutting diagnosis errors by 16% and treatment errors by 13% across 20,000 patient visits, while unexpectedly boosting clinician confidence by delivering silent, targeted corrective nudges during care.
Columbia University researchers are deploying cutting-edge AI tools to decode the molecular complexity of human biology, uncovering hidden genetic drivers of pediatric leukemia, Alzheimer's, and cancer in a landmark shift toward predictive, personalized medicine.
A groundbreaking NHS AI mammography system detects 25% more missed cancers while cutting radiologist workload by up to 44%, offering a powerful solution to the UK's radiologist shortage, though human panels incorrectly overruled the AI on 93 cancer cases, highlighting urgent need for improved human-AI collaboration.
NVIDIA is partnering with robotics giants ABB, FANUC, KUKA, Medtronic, and others to deploy physical AI at industrial scale, unveiling powerful new tools including Cosmos 3, Isaac Lab 3.0, and GR00T N2—currently ranked No. 1 on multiple robotics benchmarks—spanning manufacturing, warehousing, and surgical robotics.
Amazon launches Health AI, a HIPAA-compliant agentic assistant giving Prime members 24/7 personalized health guidance, lab result explanations, and up to five free medical consultations with One Medical providers — a value of up to $145 at no extra cost.
MIT researchers unveil a breakthrough AI technique that makes computer vision models both more accurate and explainable by extracting learned concepts and translating them into plain-language descriptions, outperforming existing interpretable models in tasks like bird species identification and skin lesion detection.
At MWC's 4YFN showcase, AI startups are proving real-world impact beyond frontier models, with Ultralytics hitting 2.5 billion inferences, Biorce raising $52 million for clinical trials, and NeuralTrust securing EU backing to protect enterprise AI systems from cyber threats.
MIT and Microsoft researchers are using AI to design nanoparticle sensors that detect early-stage cancer through a simple urine test, with scientists now working to develop an at-home diagnostic kit capable of identifying up to 30 types of cancer.